A Study of ILB2109 in Patients With Advanced Solid Malignancies
Clinical trial NCT05278546 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05278546
- Sponsor
- Innolake Biopharm
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-11
- Primary completion
- 2024-12-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.